HTGCHercules Capital, Inc.

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

CION's Q2 results benefit from lower non-accruals, lifting shares 16.9%. However, lower investment income and higher expenses weigh on results.

MAIN's Q2 NII misses estimates as higher expenses offset gains from increased investment income and portfolio activity.

While income investors keep circling the same REITs and MLPs, three finance-sector names with yields that dwarf typical dividend stalwarts have been hiding in plain sight, and the safety case for each one is stronger than the headline numbers suggest.

Hercules Capital stock has delivered a 63.8% gain over the past five years, yet several valuation checks suggest the current share price of US$16.42 may still sit below what the business is worth. Both the intrinsic value estimate based on the Excess Returns model and the market multiple checks currently point in the same direction, which puts extra focus on whether the recent share price weakness this year has already accounted for key risks. Over five years Hercules Capital has returned...

Hercules Capital, Inc. reported strong past results for the second quarter and first half of 2026, with Q2 revenue rising to US$149.11 million and net income to US$130.18 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. Alongside these earnings, Hercules Capital increased its regular quarterly dividend to US$0.47 per share, declared a US$0.07 supplemental distribution, and recently completed a US$321.27 million fixed‑income...

Why Hercules Capital’s latest quarter matters for shareholders Hercules Capital (HTGC) just reported Q2 2026 results that featured record originations, investment income and net investment income, alongside higher revenue and net income and early loan repayments that ran ahead of guidance. Management also highlighted steady portfolio credit quality, strong liquidity and ongoing contributions from the company’s private credit business. Taken together, these factors framed Q2 as an important...

Hercules Capital's shares up 3% after Q2 earnings meet estimates and record total investment income climbs 8.5%, while higher expenses weigh on performance.

Hercules Capital (NYSE:HTGC) reported record second-quarter investment income and net investment income, supported by strong originations, elevated early loan repayments and stable portfolio credit performance. Chief Executive Officer and Chief Investment Officer Scott Bluestein said the business c

Hercules Capital Inc (HTGC) posts record Q2 2026 investment income and NAV growth, navigating competitive pressures with disciplined underwriting and robust portfolio health.

Record originations of $2.74 billion drove net investment income to $92.9 million.

Hercules Capital (HTGC) delivered earnings and revenue surprises of 0.00% and +0.14%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Specialty finance company Hercules Capital (NYSE:HTGC) will be announcing earnings results this Thursday after market close. Here’s what to look for.

In the latest trading session, Hercules Capital (HTGC) closed at $15.93, marking a -1.24% move from the previous day.

The latest trading day saw Hercules Capital (HTGC) settling at $16.37, representing a +1.61% change from its previous close.

Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the 10 affordable biotech stocks to buy right now. On June 26, TD Cowen initiated its coverage of Dyne Therapeutics Inc. (NASDAQ:DYN), assigning a Buy rating to the stock. The firm stated that the company’s Force platform has the potential to improve drug delivery in neuromuscular and CNS diseases […]

PhenixFIN (PFX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.